Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(85)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(106)
- Bcl-xL(8)
- c-RET(9)
- IAP(26)
- KEAP1-Nrf2(64)
- MDM2(12)
- p53(112)
- PC-PLC(4)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(6)
- Thymidylate Synthase(10)
- TNF-α(128)
- Other Apoptosis(885)
- APC(5)
- PD-1/PD-L1 interaction(60)
- ASK1(3)
- PAR4(2)
- RIP kinase(50)
- FKBP(19)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
-
GC45204
α-Ecdysone
蜕皮激素; α-Ecdysone
蜕皮激素(α-蜕皮激素)是一种存在于昆虫和植物中的类固醇蜕皮激素,可激活盐皮质激素受体(MR),从而导致肾小球疾病。
-
GC45193
Z-YVAD-CMK (trifluoroacetate salt)
Benxyloxycarbonyl-Tyr-Val-Ala-Asp-Chloromethylketone, Caspase-1 Inhibitor IV
An inhibitor of caspase-1 and caspase-3 -
GC45191
Z-VDVAD-pNA (trifluoroacetate salt)
Z-VDVAD-p-nitroanilide, Z-Val-Asp-Val-Ala-Asp-pNA, Z-Val-Asp-Val-Ala-Asp-p-nitroanilide
A colorimetric caspase-2 substrate -
GC45190
Z-VDVAD-AFC (trifluoroacetate salt)
Z-Val-Asp-Val-Ala-Asp-AFC, Z-Val-Asp-Val-Ala-Asp-7-amino-4-trifluormethylcoumarin
A fluorogenic substrate for caspase-2 -
GC45189
Z-VAD(OH)-FMK
Z-VAD(OH)-FMK
Z-VAD(OH)-FMK是所有半胱天冬酶的不可逆三肽抑制剂。 -
GC45181
Z-IETD-AFC
Z-异亮氨酰-谷氨酰-苏氨酰-天冬氨酸-AFC
A fluorogenic substrate for caspase-8 and granzyme B -
GC45178
Z-DEVD-CMK (trifluoroacetate salt)
Z-Asp-Glu-Val-Asp-CMK
An irreversible protease inhibitor -
GC45177
Z-AEVD-FMK
Z-Ala-Glu-Val-Asp-Fluoromethyl Ketone
A caspase-10 inhibitor -
GC45175
YVAD-CHO (trifluoroacetate salt)
H-Tyr-Val-Ala-Asp-CHO
A caspase-1/ICE inhibitor -
GC45149
VK3-OCH3
Vitamin K3-OCH3
An analog of vitamin K3 -
GC45132
Ursodeoxycholic Acid (sodium salt)
熊去氧胆酸钠盐; Ursodeoxycholate sodium; Ursodiol sodium; UCDA sodium
A secondary bile acid -
GC45090
Triparanol
曲帕拉醇,MER-29
An inhibitor of DHCR24 -
GC45066
Tosyl Phenylalanyl Chloromethyl Ketone
L-1,4'-甲基磺酰基-2-苯基乙基氯甲基酮,L-1-Tosylamido-2-phenylethyl chloromethyl ketone; L-TPCK
An inhibitor of chymotrypsin-like serine proteases -
GC45039
Thiocolchicine
硫代秋水仙碱
An inhibitor of microtubule assembly -
GC45031
Thiamine (hydrochloride)
Aneurine, Vitamin B1
Thiamine is a water-soluble vitamin with antioxidant, neuroprotective, and anxiolytic properties. - GC45014 Termitomycamide B A fatty acid amide that protects against ER stress-dependent cell death
-
GC44992
Taurochenodeoxycholic Acid (sodium salt)
牛磺鹅去氧胆酸钠盐; 12-Deoxycholyltaurine sodium
A taurine-conjugated form of chenodeoxycholic acid -
GC44989
TAN 420E
Dihydroherbimycin A
A bacterial metabolite -
GC44981
T-2 Toxin
T-2毒素(镰刀菌属),T-2 Mycotoxin
A trichothecene mycotoxin -
GC44973
Sultriecin
BU-3285T, Phostriecin
A fungal metabolite -
GC44967
Suc-YVAD-AMC (acetate)
Suc-Tyr-Val-Ala-Asp-AMC, Suc-Tyr-Val-Ala-Asp-7-amino-4-methylcoumarin, Suc-YVAD-NH-Mec
A fluorogenic substrate for caspase-1 -
GC44956
Streptochlorin
3-(4-氯-5-恶唑基)-1H-吲哚
A bacterial metabolite with diverse biological activities -
GC44953
Sterigmatocystin
甾体半胱氨酸
甾体半胱氨酸是由曲霉属真菌产生的一种霉菌毒素。 -
GC44943
sPLA2 Inhibitor
KH064, Secretory Phospholipase A2 Inhibitor
An orally active inhibitor of sPLA2-IIA -
GC44899
SLF
Synthetic Ligand of FKBP
A synthetic FK-506 Binding Protein (FKBP) ligand -
GC44897
SL 01
N-苯氧基碳-L-苯丙氨酰甲基氯酮,SL-01
An inhibitor of SARS-CoV Mpro - GC44896 SKI 178 A non-selective inhibitor of SPHK1 and SPHK2
-
GC44892
Siomycin A
盐霉素 A
An inhibitor of FoxM1 -
GC44888
SI-2
EPH 116
An inhibitor of SRC-3 -
GC44880
SD 1029
JAK2 Inhibitor III, Janus-Associated Kinase 2 Inhibitor III
A JAK2 inhibitor - GC44839 Ridaifen-B An analog of tamoxifen
-
GC44826
Rhapontin
土大黄苷; Rhaponiticin
A stilbenoid glycoside - GC44820 Resveratrol-3-O-Sulfate (sodium salt) An active metabolite of resveratrol
- GC44813 Resistoflavine A cytotoxic Streptomyces metabolite
- GC44786 Pyridoxatin A fungal metabolite with diverse biological activities
-
GC44730
proTAME
Pro-N-4-tosyl-L-arginine methyl ester
A prodrug form of TAME -
GC44707
Prostaglandin D2 Ethanolamide
PGD2EA, Prostamide D2
An endogenous anandamide metabolite -
GC44689
Procyanidin C1
原花青素 C1; PCC1
原花青素C1是一种多酚类化合物,存在于多种蔬菜和水果中,具有广泛的生物活性,包括抗氧化和抗炎抗癌作用 /p>\n原花青素 C 是一种从肉桂皮层纯化的儿茶素三聚体,它对 TGF-β 诱导的 EMT 显示出抑制活性。 - GC44652 PK7242 (maleate) An inducer of reactivation of mutant p53
-
GC44640
Phytosphingosine
植物鞘氨醇
A sphingolipid -
GC44633
Phosphatidylserines (bovine)
PtdSers (bovine)
A glycerophospholipid -
GC44616
PGPC
1-Palmitoyl-2-glutaryl phosphatidylcholine
An oxidized phospholipid - GC44615 PGP-4008 A selective P-glycoprotein inhibitor
- GC44603 Petromurin C A fungal metabolite
-
GC44600
Periplocin
杠柳毒苷
A cardiac glycoside -
GC44587
PDMP (hydrochloride)
DL-erythro/threo-PDMP
An inhibitor of sphingolipid biosynthesis - GC44584 PD 168368 An antagonist of NMB receptors
-
GC44528
p,p'-DDT
4,4'-DDT, 4,4'-Dichlorodiphenyltrichloroethane, p,p'-Dichlorodiphenyltrichloroethane, Dicophaner, NSC 8939
p,p'-DDT is an organochlorine pesticide that induces 94.2% mortality of malaria mosquito (A. -
GC44453
Nornidulin
降巢麴菌素
A depsidone with antibacterial activity -
GC44409
Nivalenol
雪腐镰刀菌烯醇
A trichothecene mycotoxin